In the pipeline from Derek Lowe – Page 10
-
Opinion
Reliable reactions
Derek Lowe discusses the problem of leaning too heavily on favourite reactions
-
Opinion
Difficult diseases to drug
Derek Lowe wonders why some diseases are easier to drug than others
-
Opinion
Beautiful chemistry
Derek Lowe considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder
-
Opinion
Formulation chemist friction
Derek Lowe wonders where we'd be without the formulation chemists
-
Opinion
Collaborative compromise
Derek Lowe wonders about pharmaceutical companies' motives for collaboration
-
Opinion
Prescription unknowns
Derek Lowe considers what we think we know about how drugs work once we've taken them
-
Opinion
Stick to the steps
Derek Lowe considers the problems of addressing drug development out of sequence
-
Opinion
A new wave of consolidation
Derek Lowe worries that mergers are upsetting the balance of the pharmaceutical ecosystem
-
Opinion
Cutting-edge technology for cutting-edge results?
How important is it to have the best equipped lab, wonders Derek Lowe
-
Opinion
A means to an end
Derek Lowe remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
-
Opinion
Reaction variety – the spice of life?
Derek Lowe is looking for a little more variety among his reactions
-
Opinion
Divided by a common language
Derek Lowe dreams of the day when chemists and biologists can understand each other
-
Opinion
A dose of realism
The recent row over antidepressants reminds us how little we know about the brain, says Derek Lowe